Difference between revisions of "Futilimab"
From Gomerpedia
(Created page with "400px|thumb|right '''Futilimab''' is a monoclonal antibody indicated in the treatment of metastatic cancer complicated by septic shock, mul...") |
(No difference)
|
Latest revision as of 15:13, 5 October 2017
Futilimab is a monoclonal antibody indicated in the treatment of metastatic cancer complicated by septic shock, multi-organ system failure, and death.[1] The drug costs about $4,000,000,000 per infusion, is infused rectally over 35 days, and extends life-expectancy by an average of 3 minutes. When used with hospicillin, the effects of futilimab are synergistic.
Related Topics
References